While the success rate of process development services for CAR-T cell manufacturing is highly dependent on the scFv or VHH, lentivirus manufacturing, T cell processing and engineering with lentiviruses, and in vitro and in vivo quality control assays, Celvab can not guarantee 100% success rate, our in-house data show a success rate greater than 90%.
Fast turnaround of process development services for CAR-T cell manufacturing: 6-7 months.
We have a lot of experience in dealing with difficult-to-manufacture CAR-T cell.